Avestar Capital, LLC Pfizer Inc Transaction History

Avestar Capital, LLC

$965 Million
Q2 2024

A detailed history of Avestar Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Avestar Capital, LLC holds 35,463 shares of PFE stock, worth $973,813. This represents 0.1% of its overall portfolio holdings.

Number of Shares

35,463

Previous 26,266 35.01%

Holding current value

$973,813

Previous $728,000 36.26%

% of portfolio

0.1%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $232,316 - $272,231	9,197 Added 35.01%	35,463 $992,000
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $152,310 - $174,901	5,883 Added 28.86%	26,266 $728,000
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $84,216 - $109,388	3,223 Added 18.78%	20,383 $586,000
Q3 2023 Oct 20, 2023	BUY	$32.09 - $37.51 $19,446 - $22,731	606 Added 3.66%	17,160 $569,000
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $44,716 - $51,736	-1,238 Reduced 6.96%	16,554 $607,000
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $96,505 - $125,636	-2,450 Reduced 12.1%	17,792 $725,000
Q4 2022 Jan 20, 2023	BUY	$41.75 - $54.5 $149,506 - $195,164	3,581 Added 21.49%	20,242 $0
Q3 2022 Oct 26, 2022	SELL	$43.76 - $53.42 $153,816 - $187,771	-3,515 Reduced 17.42%	16,661 $729,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $154,991 - $183,771	3,331 Added 19.77%	20,176 $1.06 Million
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $148,275 - $183,732	3,241 Added 23.82%	16,845 $872,000
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $27,684 - $41,037	-670 Reduced 4.69%	13,604 $803,000
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $3,454 - $4,436	-88 Reduced 0.61%	14,274 $614,000
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $125,613 - $142,298	-3,498 Reduced 19.59%	14,362 $562,000
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $58,540 - $66,021	1,748 Added 10.85%	17,860 $693,000
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $212,534 - $270,256	6,350 Added 65.05%	16,112 $593,000
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $2,794 - $3,278	88 Added 0.91%	9,762 $370,000
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $73,944 - $89,705	2,455 Added 34.01%	9,674 $316,000
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $60,141 - $85,929	-2,225 Reduced 23.56%	7,219 $236,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $31,405 - $35,641	954 Added 11.24%	9,444 $370,000
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $108,061 - $140,124	3,326 Added 64.41%	8,490 $305,000
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $3,845 - $4,318	104 Added 2.06%	5,164 $215,000
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $1,200 - $1,318	-32 Reduced 0.63%	5,060 $207,000
Q4 2018 Jan 25, 2019	BUY	$38.47 - $43.86 $3,693 - $4,210	96 Added 1.92%	5,092 $214,000
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $66,216 - $80,317	-1,921 Reduced 27.77%	4,996 $211,000
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $9,333 - $9,950	283 Added 4.27%	6,917 $242,000
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $1,212 - $1,406	-38 Reduced 0.57%	6,634 $225,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $221,910 - $235,454	6,672	6,672 $236,000

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Pfizer Inc Transaction History